Tag Visualization: Top 50 related tags by occurrence
Halozyme scores $190M Horizon deal to develop subQ Tepezza formula
Added to Collection on: 2020-12-01 17:36:55
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
FDA Recommends Early Termination of Phase 2 Trial Investigating ERC1671 to Treat Glioblastoma
Added to Collection on: 2021-04-09 16:05:06
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Sling Therapeutics emerges with $35M to tackle thyroid eye disease - Labiotech.eu
Added to Collection on: 2022-06-15 15:12:04
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Biologics a game changer for management of thyroid eye disease - Healio
Added to Collection on: 2022-10-06 20:45:39
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Clinical Challenges: Long-Term Management of Thyroid Eye Disease | MedPage Today
Added to Collection on: 2022-10-14 19:46:52
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Clinical Overview: Teprotumumab for Thyroid Eye Disease - Pharmacy Times
Added to Collection on: 2022-11-03 17:51:21
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Xeris and Horizon enter partnership to develop teprotumumab - Pharmaceutical Technology
Added to Collection on: 2022-11-24 17:13:32
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Ropes & Gray Advises Xeris Biopharma in Research Collaboration with Horizon Therapeutics
Added to Collection on: 2022-11-30 08:21:12
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval ... - Pipelinereview
Added to Collection on: 2025-03-15 04:58:57
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of ... - BioSpace
Added to Collection on: 2025-03-14 13:51:45
Tags for this article:
Click the tags to see associated articles and topics
View Article Details